Matthew Arnold

Jul 18, 2024 | onlinelibrary.wiley.com | Navdeep Tangri |Christian Alvarez |Matthew Arnold |Salvatore Barone

1 INTRODUCTION An estimated 11% of the global population had chronic kidney disease (CKD) in 2017.1 Owing to an aging population and increasing prevalence of risk factors for CKD such as type 2 diabetes (T2D), cardiovascular disease and hypertension, this percentage will likely rise.2, 3 CKD is progressive and can lead to end-stage kidney disease, necessitating dialysis or kidney transplantation.

Jun 27, 2024 | biorxiv.org | Alice E Kane |Karthikeyani Chellappa |Michael Schultz |Matthew Arnold

AbstractNicotinamide adenine dinucleotide (NAD) is essential for many enzymatic reactions, including those involved in energy metabolism, DNA repair and the activity of sirtuins, a family of defensive deacylases. During aging, levels of NAD+ can decrease by up to 50% in some tissues, the repletion of which provides a range of health benefits in both mice and humans. Whether or not the NAD+ precursor nicotinamide mononucleotide (NMN) extends lifespan in mammals is not known.

Jun 10, 2024 | chemistry-europe.onlinelibrary.wiley.com | Michael Cortie |Annette Dowd |Matthew Arnold |Supitcha Supansomboon

Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Jan 9, 2023 | biorxiv.org | Matthew Arnold

Aug 30, 2022 | businesslive.co.za | Matthew Arnold